Researchers from institutions across the U.S. evaluated data from the Organ Preservation in Rectal Adenocarcinoma trial of 277 rectal cancer patients from April 2014 to March 2020. Based on a post-treatment MRI, patients were classified as having clinical complete response, near-complete clinical response, or incomplete clinical response.
In a five-year follow up, the disease-free survival was 81.8% for participants with clinical complete response, 67.6% for participants with near-complete clinical response and 49.6% for patients with incomplete clinical response.
Findings suggest MRI response categories can be predictive of organ preservation and survival for watch-and-wait rectal cancer patients, according to the study.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
